Open AccessAnalysis of the Clinical Effect of Combined Drug Susceptibility to Guide Medication for Carbapenem-Resistant Klebsiella pneumoniae Patients Based on the Kirby–Bauer Disk Diffusion Method
Author(s) -
Huijuan Yao,
Jingxian Liu,
Xueyan Jiang,
Feng Chen,
Xianghua Lu,
Jian Zhang
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s282386
Subject(s) - tigecycline , fosfomycin , imipenem , medicine , ceftazidime , klebsiella pneumoniae , polymyxin b , meropenem , microbiology and biotechnology , carbapenem , pharmacology , antibiotics , biology , antibiotic resistance , pseudomonas aeruginosa , bacteria , biochemistry , genetics , escherichia coli , gene
To evaluate the in-vitro antibacterial activity of drug combinations against carbapenem-resistant Klebsiella pneumoniae (CRKP) and to explore the guiding significance of the combined drug susceptibility results for determining the clinical efficacy in patients with CRKP infection.